Identification | Back Directory | [Name]
Abituzumab | [CAS]
1105038-73-0 | [Synonyms]
Abituzumab Abituzumab (anti-ITGAV) Anti-Human CD51(Abituzumab) Research Grade Abituzumab(DHC21901) |
Hazard Information | Back Directory | [Uses]
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer[1]. | [References]
[1] Jiang Y, et al. Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression. Mol Cancer Res. 2017 Jul;15(7):875-883. DOI:10.1158/1541-7786.MCR-16-0447 |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
|